Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
tirzepatide is a dual agonist (GIP/GLP-1) Peak weight loss : Retatrutide showed 28.7% at 68 weeks (Phase 3 TRIUMPH-4) and 24.2% at 48 weeks (Phase 2) vs tirzepatide 20.9% (Phase 3) Liver fat : Retatrutide's glucagon agonism provides pronounced hepatic fat reduction (up to 82%) Regulatory status : Tirzepatide is FDA-approved
Whn ft bl t b trnrtd t b ud nd burnd fr ful t rvd nrg, t nt bng trd ft ll
Patients should also be aware of potential side effects, which may include local irritation or allergic reactions, although these are generally rare
How long does it take to see results with the GLP-1 program
metabolic dysfunction-associated steatohepatitis (MASH)
When paired with L-Carnitine, the benefits expand even further
US$ 28.23
US$ 25.59
US$ 22.76
US$ 20.71
US$ 27.71
